Revenue segments as reported by the company.

Premiums earned, net

Other income

Investment income, net

Direct Contracting revenue

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Net medical claims incurred

Salaries and benefits

General and administrative expenses

Premium deficiency reserve (benefit) expense

Depreciation and amortization

Other expense

Restructuring costs

Impairment of goodwill and other intangible assets

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Clover Health Investments

Clover Health Investments Corp. provides healthcare insurance services. It uses its proprietary technology platform to collect, structure, and analyze health and behavioral data to improve medical outcomes and lower costs for patients. The company was founded on July 17, 2014 and is headquartered in Franklin, TN.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Clover Health reports profitable Q1, poised for sustained growth

Clover Health Investments had a strong Q1 performance, expecting full-year profitability and revenue growth. With a focus on operational enhancements, revenue growth, and cost reductions, the company aims to maintain momentum in 2024 amidst industry challenges. Clover's strategic initiatives like share repurchase program and product enhancements position it well for sustained growth and care management excellence.

Clover Health achieves profitability milestone and eyes market expansion

Clover Health's Q2 2024 earnings call reflects a positive trajectory with increased profitability, strong revenue growth, and improved guidance for the full year.
The company's strategic focus on operational efficiency, technology innovation, and market validation positions it well for sustainable growth and market expansion.
While facing challenges in maintaining profitability and implementing technology enhancements, Clover Health has opportunities to capitalize on market interest and drive further growth in the Medicare Advantage sector.

Clover Health reports strong Q3 performance and eyes growth opportunities

Clover Health Investments (CLOV) showcased strong financial performance and strategic investments in growth areas during the Q3 2024 earnings call. The company's focus on membership growth, quality initiatives, and technology enhancements, along with exploring health partnerships, highlights a promising outlook for future success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Clover Health Investments Corp. is a physician enablement technology company that provides Medicare Advantage plans in the United States. Its strategy is powered by its proprietary software platform, Clover Assistant, which aggregates patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic diseases. The company offers PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on its flagship wide-network, high-choice PPO plans. Clover Health Investments was founded by Vivek Garipalli and Andrew Toy on July 17, 2014 and is headquartered in Franklin, TN.

NASHVILLE, Tenn., Dec. 09, 2021 (GLOBE NEWSWIRE) -- Today, Clover Health (Nasdaq: CLOV) (“Clover”), a technology company committed to improving health equity for America's underserved seniors, announced that it will provide clinicians using the Clover Assistant with access to comprehensive renal care coordination and services to support disease management among their patients who have been diagnosed with chronic kidney disease (CKD). As part of the program, Clover is partnering with value-based kidney care provider Cricket Health to offer patients comprehensive, personalized kidney care.

Clover Health Launches New Clinical Program Targeting Chronic Kidney Disease in Partnership with Cricket Health

CLOV stock continues to punish long-suffering shareholders as it losses value. The latest public offering at the low-ball price of $5.75 is another nail in the coffin.

As Clover Health Stock Gets Diluted, Stockholders Are Giving Up

Camber Energy

GSX Techedu Inc.

Which penny stocks are you watching right now? The post Making a Penny Stocks Watchlist?

Making a Penny Stocks Watchlist? 3 You Need to Know About

CLOV stock is saddled with issues that include a declining share price and operational issues that are only getting more troublesome. The post Clover Health Is Now a Penny Stock, Denoting Its Serious Decline appeared first on InvestorPlace.

Clover Health Is Now a Penny Stock, Denoting Its Serious Decline

Clover Health has done a great job appealing to the biggest CLOV stock fans on Reddit, but great publicity doesn't make it profitable. The post Clover Health Appeals to Its Base, But Profits Are in the Distant Future appeared first on InvestorPlace.

Clover Health Appeals to Its Base, But Profits Are in the Distant Future

Likely to languish at or below $5 per share for a while, skip out for now with CLOV stock. The post With Hope and Hype Gone, Clover Health Will Now Remain a Penny Stock appeared first on InvestorPlace.

With Hope and Hype Gone, Clover Health Will Now Remain a Penny Stock

The company reported earnings and announced a common stock offering last month.

Why Clover Health Tanked 33.9% in November

15 out of 20 top institutional shareholders are buying CLOV at the dip. Despite the lack of urgency for raising capital, management's decision to sell equity is rational, sparing the risk of more dilution if share prices drop.

Clover Health: Roles Reversed As Institutions Buy The Dip And Retail Investors Bottle Out

November was brutal for shareholders of Clover Health. CLOV stock lost close to 40% of its value.

If November Is Any Indication, Clover Health Is on Life Support

The Clover Assistant is meant to align incentives between health care providers and managed care companies, which could cut costs and create profits. That's what CLOV stock investors should focus on.

The Engine Boosting Clover Health Stock is a CTO Working to Disrupt Medicare

Last rites for Clover Health Investments seem premature, but CLOV stock is being challenged off and on the price chart. The post The Clover Health Dilemma: Is it a Good Buy or Goodbye?

The Clover Health Dilemma: Is it a Good Buy or Goodbye?

Is Clover Health Stock a Buy?

Clover provides a relevant solution and is expanding, but its cash flow makes CLOV stock an unattractive pick at this point. The post Clover Health Is Expanding, But Its Path to Profitability Is Unclear appeared first on InvestorPlace.

Clover Health Is Expanding, But Its Path to Profitability Is Unclear

Express

Meta Materials

Phunware Inc

Progenity

Lordstown Motors

Before you close the books on 2021, if you hold a position in any of these seven penny stocks to sell, make sure to make your exit. Camber Energy (NYSEAMERICAN:CEI) Clover Health (NASDAQ:CLOV) Express (NYSE:EXPR) Meta Materials (NASDAQ:MMAT) Phunware (NASDAQ:PHUN) Progenity (NASDAQ:PROG) Lordstown Motors (NASDAQ:RIDE) The post 7 Penny Stocks to Sell Before Year End appeared first on InvestorPlace.

7 Penny Stocks to Sell Before Year End

NASHVILLE, Tenn., Nov. 23, 2021 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV), (“Clover Health”), a technology company committed to improving health equity for seniors, today announced the closing on November 22, 2021, of its previously announced underwritten public offering of shares of its Class A Common Stock, resulting in approximately $300 million of gross proceeds.

Clover Announces Closing of Public Offering of Class A Common Stock

Bright Health Group

Oscar Health

Temporary conditions related to COVID-19 have been a huge drag on earnings, but the trouble could subside soon.

3 Beaten-Down Insurtech Stocks That Could Bounce Back in 2022

Clover Health Investments (CLOV) stock is getting a boost on Friday thanks to a couple of Tweets from Chamath Palihapitiya. The post CLOV Stock: The Chamath Palihapitiya Tweet Giving Clover Health a Lift Today appeared first on InvestorPlace.

CLOV Stock: The Chamath Palihapitiya Tweet Giving Clover Health a Lift Today

Meme stock favorite Clover Health is under pressure today after announcing a new secondary stock offering that has upset investors. The post CLOV Stock Alert: There's a $300M Reason Clover Health Is Stumbling Today appeared first on InvestorPlace.

CLOV Stock Alert: There's a $300M Reason Clover Health Is Stumbling Today

NASHVILLE, Tenn., Nov. 17, 2021 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV), (“Clover Health”), a technology company committed to improving health equity for seniors, today announced the pricing of its previously announced underwritten public offering of 52,173,913 shares of its Class A Common Stock at a price of $5.75 per share. In addition, Clover Health has granted the underwriters a 30-day option to purchase up to 7,826,086 additional shares of its Class A Common Stock at the public offering price, less the underwriting discounts and commissions. The aggregate gross proceeds to Clover Health from the offering are expected to be approximately $300 million, before deducting underwriting discounts and commissions and offering expenses and assuming no exercise of the underwriters' option to purchase additional shares. All of the shares are being offered by Clover Health. The offering is expected to close on or about November 22, 2021, subject to the satisfaction of customary closing conditions.

Clover Health Investments, Corp. Announces Pricing of $300 Million Upsized Public Offering of Class A Common Stock

Investors need to pay close attention to Clover Health (CLOV) stock based on the movements in the options market lately.

Implied Volatility Surging for Clover Health (CLOV) Stock Options

The stock price of Clover Health Investments Corp (NASDAQ: CLOV) fell by over 9% during intraday trading today. This is why it happened.

Clover Health (CLOV) Stock: Why The Price Fell Today

Clover Health Investments Corp (NASDAQ: CLOV) shares are trading lower after the company reported a 35 million share common stock offering during Monday's after-hours session. All of the shares are being offered by Clover Health.

Why Clover Health Shares Are Falling

The Medicare tech company just gave some disappointing news.

Here's Why Clover Health Is Falling Today

A combination of triple-digit growth, expanding provider networks and a low share price make CLOV stock hard to resist. The post Revenue Growth Makes Clover Health Stock a Strong Buy appeared first on InvestorPlace.

Revenue Growth Makes Clover Health Stock a Strong Buy

NASHVILLE, Tenn., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV), (“Clover Health”), a technology company committed to improving health equity for seniors, today announced that it has commenced an underwritten public offering of 35,000,000 shares of its Class A Common Stock. All of the shares are being offered by Clover Health. In conjunction with the offering, Clover Health intends to grant to the underwriters a 30-day option to purchase up to 5,250,000 additional shares of its Class A Common Stock. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

News for Clover Health Investments Stock (CLOV)